ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00BFNM3G45
Stock Name / FundiShares MSCI USA ESG Screened UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerSASU(USD) LSE
ETF TickerGPSA(GBP) LSE
ETF TickerSGAS(EUR) F
ETF TickerGPSA.LS(GBP) CXE
ETF TickerSASU.LS(USD) CXE
ETF TickerSASUz(USD) CXE
ETF TickerSGAS.DE(EUR) CXE
ETF TickerSASU.L(GBP) LSE
ETF TickerGPSA.L(GBP) LSE

Holdings detail for NBIX

Stock NameNeurocrine Biosciences Inc
TickerNBIX(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS64125C1099
LEI549300FECER0XBN49756

Show aggregate NBIX holdings

News associated with NBIX

Sum Up The Parts: SCHG Could Be Worth $34
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-21 10:23:31
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Sold by Maryland State Retirement & Pension System
Maryland State Retirement & Pension System lowered its position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 12.5% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,661 shares of the company’s stock after selling 663 shares during the quarter. Maryland […] - 2025-08-15 05:24:56
Charles Schwab Investment Management Inc. Purchases 13,216 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Charles Schwab Investment Management Inc. raised its position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 1.7% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 775,773 shares of the company’s stock after acquiring an additional 13,216 shares during the quarter. Charles […] - 2025-08-13 05:10:46
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Sold by Blair William & Co. IL
Blair William & Co. IL cut its stake in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 3.7% in the first quarter, Holdings Channel reports. The fund owned 6,214 shares of the company’s stock after selling 242 shares during the period. Blair William & Co. IL’s holdings in Neurocrine Biosciences were worth $687,000 at the […] - 2025-08-11 05:52:52
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Sold by Federated Hermes Inc.
Federated Hermes Inc. trimmed its holdings in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 72.9% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 9,441 shares of the company’s stock after selling 25,402 shares during the quarter. Federated Hermes Inc.’s […] - 2025-08-07 05:22:58
Natixis Advisors LLC Sells 292 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Natixis Advisors LLC lowered its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 0.9% in the first quarter, Holdings Channel.com reports. The institutional investor owned 33,312 shares of the company’s stock after selling 292 shares during the period. Natixis Advisors LLC’s holdings in Neurocrine Biosciences were worth $3,684,000 at the end of the […] - 2025-08-07 04:49:07
Neurocrine (NBIX) Q2 2025 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo - 2025-08-05 01:16:10
Neurocrine (NBIX) Q2 Revenue Jumps 17%
Key PointsNon-GAAP earnings per share of $1.65 for Q2 2025 vastly exceeded the analyst estimate of $0.96. - 2025-08-01 01:15:16
13,202 Shares in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Bought by Y Intercept Hong Kong Ltd
Y Intercept Hong Kong Ltd acquired a new position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) in the 1st quarter, HoldingsChannel.com reports. The fund acquired 13,202 shares of the company’s stock, valued at approximately $1,460,000. Other hedge funds and other institutional investors have also recently bought and sold shares of the company. […] - 2025-07-24 06:50:57
HighPoint Advisor Group LLC Purchases 366 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
HighPoint Advisor Group LLC boosted its position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 15.0% during the first quarter, Holdings Channel.com reports. The fund owned 2,812 shares of the company’s stock after acquiring an additional 366 shares during the quarter. HighPoint Advisor Group LLC’s holdings in Neurocrine Biosciences were worth $302,000 […] - 2025-07-24 05:51:14
Neurocrine Biosciences (NASDAQ:NBIX) Now Covered by Analysts at Truist Financial
Truist Financial initiated coverage on shares of Neurocrine Biosciences (NASDAQ:NBIX – Free Report) in a research report report published on Monday, Marketbeat reports. The firm issued a buy rating and a $163.00 price target on the stock. NBIX has been the subject of several other reports. Royal Bank Of Canada reaffirmed an “outperform” rating and […] - 2025-07-22 04:28:48
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Position Trimmed by Cerity Partners LLC
Cerity Partners LLC decreased its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 20.1% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 33,361 shares of the company’s stock after selling 8,376 shares during the quarter. Cerity Partners LLC’s holdings in […] - 2025-07-18 04:55:08
Ingrid Delaet Sells 457 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Stock
Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) insider Ingrid Delaet sold 457 shares of the business’s stock in a transaction on Thursday, July 10th. The stock was sold at an average price of $135.00, for a total transaction of $61,695.00. Following the completion of the transaction, the insider directly owned 4,730 shares in the […] - 2025-07-14 07:16:47
Bank of New York Mellon Corp Has $91.65 Million Stock Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Bank of New York Mellon Corp lessened its holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 4.8% during the first quarter, HoldingsChannel reports. The fund owned 828,682 shares of the company’s stock after selling 41,608 shares during the quarter. Bank of New York Mellon Corp’s holdings in Neurocrine Biosciences were worth $91,652,000 as […] - 2025-07-11 05:40:57
Principal Financial Group Inc. Has $27.48 Million Stock Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Principal Financial Group Inc. reduced its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 1.6% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 248,420 shares of the company’s stock after selling 4,049 shares during the period. Principal Financial Group Inc. owned 0.25% of Neurocrine Biosciences […] - 2025-07-09 05:51:40
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Given Average Recommendation of “Moderate Buy” by Analysts
Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the twenty-two brokerages that are presently covering the stock, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation and nineteen have given a buy recommendation to the company. The average 12 […] - 2025-07-09 03:09:50
First Horizon Advisors Inc. Has $43,000 Stock Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
First Horizon Advisors Inc. decreased its position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 55.5% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 385 shares of the company’s stock after selling 480 shares during the quarter. First Horizon Advisors […] - 2025-07-08 05:49:06
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Insider Jude Onyia Sells 20,362 Shares
Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) insider Jude Onyia sold 20,362 shares of the company’s stock in a transaction on Wednesday, July 2nd. The stock was sold at an average price of $130.13, for a total value of $2,649,707.06. Following the completion of the sale, the insider owned 18,289 shares of the company’s […] - 2025-07-08 05:06:50
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Sold by KBC Group NV
KBC Group NV lessened its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 3.5% in the 1st quarter, Holdings Channel reports. The fund owned 13,835 shares of the company’s stock after selling 495 shares during the period. KBC Group NV’s holdings in Neurocrine Biosciences were worth $1,530,000 as of its most recent filing […] - 2025-07-04 06:58:45
New York State Teachers Retirement System Lowers Stock Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
New York State Teachers Retirement System lowered its stake in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 1.9% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 108,481 shares of the company’s stock after selling 2,055 shares during the quarter. New York State Teachers Retirement System’s holdings in Neurocrine Biosciences were worth $11,998,000 […] - 2025-07-04 06:14:58
Amalgamated Bank Has $5.28 Million Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Amalgamated Bank lessened its holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 3.8% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 47,719 shares of the company’s stock after selling 1,895 shares during the quarter. Amalgamated Bank’s holdings in Neurocrine Biosciences were […] - 2025-07-03 06:14:49
Sumitomo Mitsui Trust Group Inc. Sells 1,399 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Sumitomo Mitsui Trust Group Inc. reduced its holdings in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 0.6% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 231,458 shares of the company’s stock after selling 1,399 shares during the quarter. Sumitomo Mitsui Trust […] - 2025-07-03 05:35:01
Golden State Wealth Management LLC Grows Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Golden State Wealth Management LLC increased its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 116.9% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 397 shares of the company’s stock after purchasing an additional 214 shares during the quarter. […] - 2025-07-02 05:01:01
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Acquired by Oppenheimer & Co. Inc.
Oppenheimer & Co. Inc. raised its holdings in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 2.4% in the 1st quarter, HoldingsChannel.com reports. The fund owned 19,388 shares of the company’s stock after buying an additional 447 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in Neurocrine Biosciences were worth $2,144,000 as […] - 2025-06-27 05:10:49
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Sold by Retirement Systems of Alabama
Retirement Systems of Alabama cut its holdings in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 1.4% in the 1st quarter, Holdings Channel reports. The firm owned 121,352 shares of the company’s stock after selling 1,755 shares during the period. Retirement Systems of Alabama’s holdings in Neurocrine Biosciences were worth $13,422,000 at the […] - 2025-06-23 05:04:51
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Bought by QRG Capital Management Inc.
QRG Capital Management Inc. lifted its position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 7.1% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 20,062 shares of the company’s stock after buying an additional 1,330 shares […] - 2025-06-20 06:54:59
Sowell Financial Services LLC Takes Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Sowell Financial Services LLC bought a new stake in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 4,786 shares of the company’s stock, valued at approximately $529,000. Other institutional investors and hedge funds […] - 2025-06-20 05:29:06
Trust Point Inc. Sells 660 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Trust Point Inc. decreased its holdings in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 26.6% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,823 shares of the company’s stock after selling 660 shares during the period. Trust Point Inc.’s holdings in […] - 2025-06-19 05:35:02
XBI, EXAS, NBIX, NTRA: ETF Outflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $443.9 million dollar outflow -- that's a 8.8% decrease week over week - 2025-06-17 11:54:37
Merit Financial Group LLC Acquires 345 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Merit Financial Group LLC raised its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 9.1% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,153 shares of the company’s stock after purchasing an additional 345 shares during the quarter. Merit Financial Group […] - 2025-06-11 05:00:51

iShares MSCI USA ESG Screened UCITS ETF USD (Acc) NBIX holdings

DateNumber of NBIX Shares HeldBase Market Value of NBIX SharesLocal Market Value of NBIX SharesChange in NBIX Shares HeldChange in NBIX Base ValueCurrent Price per NBIX Share HeldPrevious Price per NBIX Share Held
2025-12-18 (Thursday)31,822NBIX holding decreased by -108USD 4,513,632NBIX holding decreased by -10849USD 4,513,632-108USD -10,849 USD 141.84 USD 141.7
2025-12-17 (Wednesday)31,930NBIX holding increased by 108USD 4,524,481NBIX holding decreased by -208723USD 4,524,481108USD -208,723 USD 141.7 USD 148.74
2025-12-16 (Tuesday)31,822NBIX holding increased by 124USD 4,733,204NBIX holding decreased by -110250USD 4,733,204124USD -110,250 USD 148.74 USD 152.8
2025-12-12 (Friday)31,698NBIX holding increased by 132USD 4,843,454NBIX holding decreased by -41385USD 4,843,454132USD -41,385 USD 152.8 USD 154.75
2025-12-11 (Thursday)31,566NBIX holding increased by 18USD 4,884,839NBIX holding decreased by -24976USD 4,884,83918USD -24,976 USD 154.75 USD 155.63
2025-12-10 (Wednesday)31,548NBIX holding increased by 66USD 4,909,815NBIX holding increased by 14049USD 4,909,81566USD 14,049 USD 155.63 USD 155.51
2025-12-05 (Friday)31,482NBIX holding decreased by -6USD 4,895,766NBIX holding increased by 39687USD 4,895,766-6USD 39,687 USD 155.51 USD 154.22
2025-12-04 (Thursday)31,488NBIX holding decreased by -60USD 4,856,079NBIX holding increased by 62045USD 4,856,079-60USD 62,045 USD 154.22 USD 151.96
2025-12-03 (Wednesday)31,548NBIX holding increased by 36USD 4,794,034NBIX holding decreased by -10916USD 4,794,03436USD -10,916 USD 151.96 USD 152.48
2025-12-02 (Tuesday)31,512NBIX holding increased by 528USD 4,804,950NBIX holding increased by 90425USD 4,804,950528USD 90,425 USD 152.48 USD 152.16
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of NBIX by Blackrock for IE00BFNM3G45

Show aggregate share trades of NBIX

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-12-18SELL-108144.230141.230 141.530USD -15,285 126.60 Loss of -1,612 on sale
2025-12-17BUY108150.470141.610 142.496USD 15,390 126.54
2025-12-16BUY124155.230148.135 148.844USD 18,457 126.45
2025-12-12BUY132155.290151.170 151.582USD 20,009 126.33
2025-12-11BUY18156.460153.300 153.616USD 2,765 126.21
2025-12-10BUY66156.695151.590 152.100USD 10,039 126.08
2025-12-05SELL-6156.760153.375 153.713USD -922 125.95 Loss of -167 on sale
2025-12-04SELL-60 154.220* 125.83 Profit of 7,550 on sale
2025-12-03BUY36154.350150.260 150.669USD 5,424 125.71
2025-12-02BUY528153.790150.855 151.148USD 79,806 125.59
2025-11-28BUY60153.700150.410 150.739USD 9,044 125.48
2025-11-26SELL-18153.540146.000 146.754USD -2,642 125.24 Loss of -387 on sale
2025-11-26SELL-18153.540146.000 146.754USD -2,642 125.24 Loss of -387 on sale
2025-11-25BUY102144.750140.667 141.075USD 14,390 125.16
2025-11-24BUY222143.505139.270 139.694USD 31,012 125.09
2025-11-20BUY6 138.980* 125.02
2025-11-19BUY36 138.060* 124.96
2025-11-18BUY108145.080138.430 139.095USD 15,022 124.90
2025-11-17BUY48145.905142.440 142.787USD 6,854 124.82
2025-11-14SELL-36146.375142.990 143.329USD -5,160 124.72 Loss of -670 on sale
2025-11-12BUY216148.035145.410 145.673USD 31,465 124.53
2025-11-10BUY120154.100146.020 146.828USD 17,619 124.30
2025-11-07SELL-12 152.370* 124.17 Profit of 1,490 on sale
2025-11-06SELL-24155.640152.860 153.138USD -3,675 124.02 Loss of -699 on sale
2025-11-05BUY78157.670147.700 148.697USD 11,598 123.88
2025-11-04BUY96143.870140.820 141.125USD 13,548 123.79
2025-11-03SELL-48144.970139.460 140.011USD -6,721 123.70 Loss of -783 on sale
2025-10-30BUY300140.190136.510 136.878USD 41,063 123.53
2025-10-29BUY300138.020144.240 143.618USD 43,085 123.46
2025-10-28BUY30147.380149.980 149.720USD 4,492 123.35
2025-10-27BUY18148.940149.330 149.291USD 2,687 123.22
2025-10-24BUY12144.000144.420 144.378USD 1,733 123.12
2025-10-21BUY18142.650142.970 142.938USD 2,573 122.82
2025-10-20BUY66141.330142.590 142.464USD 9,403 122.73
2025-10-16BUY60137.520140.730 140.409USD 8,425 122.56
2025-10-15BUY72137.730139.460 139.287USD 10,029 122.48
2025-10-06BUY54139.430140.650 140.528USD 7,589 122.24
2025-10-03BUY24137.030137.800 137.723USD 3,305 122.16
2025-10-02BUY48136.740137.630 137.541USD 6,602 122.09
2025-10-01BUY72137.000141.360 140.924USD 10,147 122.01
2025-09-30BUY438140.380141.690 141.559USD 62,003 121.91
2025-09-29BUY114140.270141.970 141.800USD 16,165 121.81
2025-09-26BUY258142.000142.080 142.072USD 36,655 121.70
2025-09-25BUY18140.890145.610 145.138USD 2,612 121.60
2025-09-18BUY72145.660146.030 145.993USD 10,511 121.46
2025-09-17BUY90142.730143.390 143.324USD 12,899 121.35
2025-09-16BUY144140.900141.020 141.008USD 20,305 121.24
2025-08-15BUY12132.900133.250 133.215USD 1,599 121.11
2025-08-13BUY7131.620131.790 131.773USD 922 121.05
2025-07-31BUY30128.230137.440 136.519USD 4,096 120.96
2025-07-29BUY120134.190135.380 135.261USD 16,231 120.80
2025-07-28BUY24133.710134.440 134.367USD 3,225 120.72
2025-07-25BUY36132.140133.120 133.022USD 4,789 120.66
2025-07-24BUY18131.640135.000 134.664USD 2,424 120.59
2025-07-23BUY42133.660134.320 134.254USD 5,639 120.52
2025-07-22BUY24132.750133.320 133.263USD 3,198 120.44
2025-07-18BUY40132.020134.940 134.648USD 5,386 120.31
2025-07-17BUY36134.110135.700 135.541USD 4,879 120.22
2025-07-07SELL-36127.880129.070 128.951USD -4,642 119.88 Loss of -327 on sale
2025-07-02SELL-150129.400130.420 130.318USD -19,548 119.70 Loss of -1,593 on sale
2025-06-27BUY23125.420127.260 127.076USD 2,923 119.63
2025-06-26BUY18126.710128.660 128.465USD 2,312 119.58
2025-06-24SELL-84128.180128.500 128.468USD -10,791 119.47 Loss of -756 on sale
2025-06-18BUY48127.310127.850 127.796USD 6,134 119.28
2025-06-17BUY18124.880125.390 125.339USD 2,256 119.24
2025-06-16SELL-24125.000126.000 125.900USD -3,022 119.20 Loss of -161 on sale
2025-06-13BUY60124.390125.540 125.425USD 7,526 119.16
2025-06-12SELL-30125.010125.910 125.820USD -3,775 119.12 Loss of -201 on sale
2025-06-11BUY66124.170125.510 125.376USD 8,275 119.09
2025-06-06BUY18125.390126.810 126.668USD 2,280 118.96
2025-06-05BUY84124.610125.240 125.177USD 10,515 118.91
2025-06-04BUY12124.520125.990 125.843USD 1,510 118.87
2025-06-03SELL-6125.000126.330 126.197USD -757 118.83 Loss of -44 on sale
2025-05-30SELL-732123.020123.930 123.839USD -90,650 118.76 Loss of -3,720 on sale
2025-05-29BUY18123.660125.630 125.433USD 2,258 118.72
2025-05-27BUY102122.640122.780 122.766USD 12,522 118.66
2025-05-23BUY90120.180120.300 120.288USD 10,826 118.64
2025-05-22BUY42119.120120.100 120.002USD 5,040 118.63
2025-05-19BUY36122.820123.070 123.045USD 4,430 118.55
2025-05-16BUY18121.020121.360 121.326USD 2,184 118.53
2025-05-15SELL-12120.270120.400 120.387USD -1,445 118.52 Loss of -22 on sale
2025-05-14BUY6118.780121.850 121.543USD 729 118.51
2025-05-13BUY12116.870119.750 119.462USD 1,434 118.53
2025-05-12BUY42120.430120.870 120.826USD 5,075 118.51
2025-05-09SELL-30115.710119.670 119.274USD -3,578 118.54 Loss of -22 on sale
2025-05-08BUY12117.520121.460 121.066USD 1,453 118.54
2025-05-07BUY18121.610122.570 122.474USD 2,205 118.52
2025-05-02BUY666109.680110.290 110.229USD 73,413 118.67
2025-04-30BUY210107.690107.980 107.951USD 22,670 118.87
2025-04-29BUY54107.240108.590 108.455USD 5,857 118.97
2025-04-28BUY42106.460108.330 108.143USD 4,542 119.08
2025-04-25BUY108106.730107.540 107.459USD 11,606 119.19
2025-04-24SELL-126105.760105.860 105.850USD -13,337 119.32 Profit of 1,697 on sale
2025-04-23BUY114103.220106.200 105.902USD 12,073 119.46
2025-04-22BUY48101.740102.680 102.586USD 4,924 119.63
2025-04-17BUY66101.380102.050 101.983USD 6,731 120.16
2025-04-15BUY6096.16098.520 98.284USD 5,897 120.58
2025-04-11BUY9690.87091.280 91.239USD 8,759 121.13
2025-04-09BUY3695.28095.560 95.532USD 3,439 121.70
2025-04-08BUY21687.54096.000 95.154USD 20,553 122.05
2025-04-07BUY7293.25096.440 96.121USD 6,921 122.35
2025-04-04SELL-9695.650100.520 100.033USD -9,603 122.62 Profit of 2,169 on sale
2025-04-02BUY816108.310108.430 108.418USD 88,469 122.78
2025-04-01BUY6107.000110.890 110.501USD 663 122.94
2025-03-31BUY42110.600112.600 112.400USD 4,721 123.08
2025-03-28BUY24113.160114.430 114.303USD 2,743 123.18
2025-03-27BUY12114.000115.800 115.620USD 1,387 123.28
2025-03-26BUY6114.450116.230 116.052USD 696 123.38
2025-03-25BUY66116.180116.230 116.225USD 7,671 123.46
2025-03-24BUY78115.600115.760 115.744USD 9,028 123.55
2025-03-21SELL-24111.920112.530 112.469USD -2,699 123.69 Profit of 269 on sale
2025-03-20BUY96110.070111.250 111.132USD 10,669 123.84
2025-03-19BUY18110.310110.690 110.652USD 1,992 124.00
2025-03-18BUY216109.700111.120 110.978USD 23,971 124.17
2025-03-17BUY42111.500112.740 112.616USD 4,730 124.33
2025-03-14BUY312110.750111.270 111.218USD 34,700 124.49
2025-03-13BUY60108.990110.210 110.088USD 6,605 124.68
2025-03-12SELL-300109.070109.560 109.511USD -32,853 124.88 Profit of 4,610 on sale
2025-03-11SELL-222107.220110.070 109.785USD -24,372 125.10 Profit of 3,401 on sale
2025-03-10BUY66110.870113.870 113.570USD 7,496 125.29
2025-03-07BUY12113.040115.000 114.804USD 1,378 125.44
2025-03-05BUY90113.850114.960 114.849USD 10,336 125.60
2025-03-04BUY102113.110114.390 114.262USD 11,655 125.76
2025-03-03BUY192114.480119.000 118.548USD 22,761 125.92
2025-02-28BUY156118.720118.930 118.909USD 18,550 126.01
2025-02-27SELL-30117.510117.850 117.816USD -3,534 126.13 Profit of 249 on sale
2025-02-25BUY222115.900120.000 119.590USD 26,549 126.40
2025-02-21BUY24120.690122.370 122.202USD 2,933 126.59
2025-02-18SELL-54113.970115.820 115.635USD -6,244 127.14 Profit of 621 on sale
2025-02-14SELL-366115.020116.970 116.775USD -42,740 127.52 Profit of 3,933 on sale
2025-02-13BUY6116.870118.610 118.436USD 711 127.69
2025-02-12BUY60117.180118.010 117.927USD 7,076 127.87
2025-02-07SELL-6122.620132.000 131.062USD -786 128.30 Loss of -17 on sale
2025-02-06BUY114150.510153.100 152.841USD 17,424 127.91
2025-02-05BUY30151.200153.090 152.901USD 4,587 127.50
2025-02-04BUY36152.420153.880 153.734USD 5,534 127.04
2025-02-03BUY36150.100151.630 151.477USD 5,453 126.62
2025-01-31BUY66151.820154.350 154.097USD 10,170 126.14
2025-01-29SELL-6150.680153.340 153.074USD -918 125.13 Loss of -168 on sale
2025-01-28SELL-54150.710152.620 152.429USD -8,231 124.62 Loss of -1,502 on sale
2025-01-27SELL-96148.190151.530 151.196USD -14,515 124.14 Loss of -2,598 on sale
2025-01-24BUY72148.730149.180 149.135USD 10,738 123.62
2025-01-23BUY12147.580148.720 148.606USD 1,783 123.11
2024-12-10BUY300128.960130.480 130.328USD 39,098 122.99
2024-12-09BUY36129.120129.420 129.390USD 4,658 122.85
2024-12-06SELL-90128.140128.930 128.851USD -11,597 122.73 Loss of -551 on sale
2024-12-05SELL-6126.420128.000 127.842USD -767 122.64 Loss of -31 on sale
2024-12-03BUY30125.440126.980 126.826USD 3,805 122.45
2024-11-27SELL-36126.590128.270 128.102USD -4,612 122.02 Loss of -219 on sale
2024-11-26BUY126127.910128.140 128.117USD 16,143 121.68
2024-11-26BUY126127.910128.140 128.117USD 16,143 121.68
2024-11-25BUY15127.110127.810 127.740USD 1,916 121.35
2024-11-25BUY15127.110127.810 127.740USD 1,916 121.35
2024-11-22SELL-12125.650127.000 126.865USD -1,522 121.22 Loss of -68 on sale
2024-11-21SELL-30125.000126.130 126.017USD -3,781 121.10 Loss of -148 on sale
2024-11-20SELL-12123.290124.010 123.938USD -1,487 121.02 Loss of -35 on sale
2024-11-19BUY6119.130119.790 119.724USD 718 121.09
2024-11-18BUY52117.620118.320 118.250USD 6,149 121.21
2024-11-11BUY18127.170129.670 129.420USD 2,330 120.50
2024-11-11BUY18127.170129.670 129.420USD 2,330 120.50
2024-11-07BUY18123.980126.650 126.383USD 2,275 119.67
2024-11-07BUY18123.980126.650 126.383USD 2,275 119.67
2024-11-06BUY144125.300126.480 126.362USD 18,196 119.08
2024-11-06BUY144125.300126.480 126.362USD 18,196 119.08
2024-11-05BUY30121.530122.000 121.953USD 3,659 118.79
2024-11-05BUY30121.530122.000 121.953USD 3,659 118.79
2024-11-04BUY12120.530122.320 122.141USD 1,466 118.56
2024-11-04BUY12120.530122.320 122.141USD 1,466 118.56
2024-11-01BUY18122.210123.000 122.921USD 2,213 118.00
2024-11-01BUY18122.210123.000 122.921USD 2,213 118.00
2024-10-30SELL-36124.330131.260 130.567USD -4,700 116.09 Loss of -521 on sale
2024-10-30SELL-36124.330131.260 130.567USD -4,700 116.09 Loss of -521 on sale
2024-10-29SELL-108116.190116.860 116.793USD -12,614 116.06 Loss of -79 on sale
2024-10-29SELL-108116.190116.860 116.793USD -12,614 116.06 Loss of -79 on sale
2024-10-28SELL-42116.200117.950 117.775USD -4,947 116.01 Loss of -74 on sale
2024-10-28SELL-42116.200117.950 117.775USD -4,947 116.01 Loss of -74 on sale
2024-10-21SELL-6116.570117.890 117.758USD -707 0.00 Loss of -707 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of NBIX

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19138,3040280,71449.3%
2025-09-18207,77644,506326,19463.7%
2025-09-17106,323343194,59754.6%
2025-09-1697,81119,146256,98038.1%
2025-09-1573,3630197,45737.2%
2025-09-1271,8171,305193,96837.0%
2025-09-1187,2040250,36934.8%
2025-09-10117,0990288,60540.6%
2025-09-09123,3791,879226,94154.4%
2025-09-08213,6691,667350,78760.9%
2025-09-05269,8828,988447,93060.3%
2025-09-04193,322481275,12970.3%
2025-09-03210,597108556,90537.8%
2025-09-02183,31915,512318,15057.6%
2025-08-29101,0617,590154,07965.6%
2025-08-28127,383487193,56165.8%
2025-08-27137,4541,818217,03363.3%
2025-08-26170,0223,558291,09658.4%
2025-08-25124,1533,639195,47663.5%
2025-08-22126,62910,885196,28864.5%
2025-08-21119,2451,265200,99059.3%
2025-08-20135,1384,637230,01058.8%
2025-08-19186,010535287,33064.7%
2025-08-18162,0387,351232,60969.7%
2025-08-15140,024100220,19963.6%
2025-08-14290,907253363,13980.1%
2025-08-13356,4048,730466,19176.5%
2025-08-12303,9754,067434,64169.9%
2025-08-11279,1915,617413,02767.6%
2025-08-08338,3850490,22069.0%
2025-08-07341,7192486,06070.3%
2025-08-06162,49452290,74155.9%
2025-08-05127,812122285,40144.8%
2025-08-04184,650798554,60133.3%
2025-08-01384,652274613,13762.7%
2025-07-31795,02721,403,51956.6%
2025-07-30277,359199566,94248.9%
2025-07-29235,4831,232479,50449.1%
2025-07-28128,7961,272304,76342.3%
2025-07-25164,9590533,68230.9%
2025-07-24143,137442360,99139.7%
2025-07-23127,087250336,56737.8%
2025-07-22110,378700199,61455.3%
2025-07-2194,76891171,48155.3%
2025-07-18136,185216238,83657.0%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy